Veracyte, Inc. Financial Ratios
VCYT / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
5.1%
Profit Margin
12.8%
Net Income / Revenue
Asset Turnover
0.37
Revenue / Total Assets
Equity Multiplier
1.07
Total Assets / Equity
Composite: 5.1% (reported: 5.1%)
Profitability
Liquidity
Current Ratio
8.15
Quick Ratio
7.81
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.37
Inventory Turnover
-
Days Sales Outstanding
32 days
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-5.2%
-1.3pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.